Ever Source Wealth Advisors, LLC Allovir, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Allovir, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 695 shares of ALVR stock, worth $382. This represents 0.0% of its overall portfolio holdings.
Number of Shares
695
Previous 695
-0.0%
Holding current value
$382
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALVR
# of Institutions
64Shares Held
44.9MCall Options Held
14.9KPut Options Held
200-
Eco R1 Capital, LLC San Francisco, CA11.3MShares$6.21 Million0.4% of portfolio
-
Octagon Capital Advisors LP New York, NY11.2MShares$6.16 Million2.19% of portfolio
-
Siren, L.L.C. New York, NY6.6MShares$3.63 Million0.27% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.28MShares$1.81 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$1.46 Million0.0% of portfolio
About Allovir, Inc.
- Ticker ALVR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,063,400
- Market Cap $51.2M
- Description
- Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...